Archive of entries posted on September 2014

A Note on Currency Risk in International Equity Investments

Posted by on

Investing in foreign stocks involves many risks one of which is currency risk. While most currencies of developed countries remain stable  in relation to the US dollar there is still the risk that currency exchange movements can reduce returns earned from equities. Unlike emerging or frontier markets investors in developed countries need not worry about dramatic …

Continue reading ‘A Note on Currency Risk in International Equity Investments’ »

A Review of the Performance of Brazilian Exchange-listed ADRs Year-To-Date

Posted by on

The Brazilian equity market has been very volatile in the past few weeks due to the upcoming general elections in October. Brazil used to be the top destination for emerging market investors up until a few years ago. Equity investors enjoyed spectacular returns when the Brazilian market as hot. For example, from 2001 to 2010 …

Continue reading ‘A Review of the Performance of Brazilian Exchange-listed ADRs Year-To-Date’ »

The Top 50 Global Pharma Companies 2014

Posted by on

The Pharmaceutical Executive magazine publishes its annual ranking of the Top 50 Pharma Companies Worldwide based on sales in the previous year. This year’s list was released back in June. The Top 50 Global Pharma Companies are listed in the tables below: Click to enlarge Source: Pharmaceutical Executive Here are a few observations: Swiss drug …

Continue reading ‘The Top 50 Global Pharma Companies 2014’ »

Comparing the Performance of Germany and France ETFs

Posted by on

The iShares MSCI Germany Index Fund(EWG) is down over 8% year-to-date while iShares MSCI France Index Fund (EWQ) is down just over 3%. The German ETF is down since German stocks has been more negatively impacted due to the Ukraine crisis. Germany has more exposure to Russia than France. Here is a quick comparsion of the two ETFs: a) …

Continue reading ‘Comparing the Performance of Germany and France ETFs’ »